More than 50 years of landmark results
Since 1967, Lowey Dannenberg has represented investors and major corporations in complex litigation, recovering billions of dollars on their behalf.Solutions for Complex Cases
Professional Recommendations
Recent Cases
Amitza
Healthcare
Lowey Dannenberg, on behalf of named plaintiff Premera Blue Cross, is leading a class on behalf of Third-Party Payers of Amitiza (Lubiprostone) against Takeda Pharmaceutical Company Ltd. and related entities. […]
Amgen
Health Care, Healthcare
On September 30, 2025, the U.S. District Court for the Eastern District of Virginia largely denied Amgen’s motion to dismiss in CareFirst of Maryland Inc. et al. v. Amgen Inc. […]
Adobe Class Action
Data Breach and Privacy, Existing Cases
On April 3, 2025, Lowey filed a data privacy class action against Adobe, Inc. alleging it used consumers’ personally identifiable information and online activity to create user profiles without obtaining […]
News
Lowey’s Noelle Feigenbaum Receives 2021 AAI Award for Outstanding Antitrust Litigation Achievement by a Young Lawyer
On November 11, 2021, Noelle Feigenbaum was honored by the American Antitrust Institute ("AAI") with the Outstanding Antitrust Litigation Achievement by a Young Lawyer award, one of two attorneys to receive the award. She was joined at AAI’s 15th annual Private...
Blog
Investors and Cannabis
Credit Suisse informed investors that it would no longer execute transactions for certain cannabis companies with US operations or hold them on behalf of clients back in March.[1] The weed industry is booming, with Cannabis being legal in Canada and a total of 36 states. It would seem that Credit...

